US Pharma MarketingIn fact, the former lost tens of billions of dollars in market value following reports of a potential tie-up between the pharmaceutical giants.
An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.
In fact, the former lost tens of billions of dollars in market value following reports of a potential tie-up between the pharmaceutical giants.
Source: BioPharma Dive